Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-22-026909

Options or other derivatives

  • President and CEO acquired 133,560 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Viehbacher Christopher President and CEO 2022-12-01 Grant or award · Stock Option +80,522 80,522 D: show line 1 in the form
Viehbacher Christopher President and CEO 2022-12-01 Grant or award · Restricted Stock Unit +7,040 7,040 D: show line 2 in the form
Viehbacher Christopher President and CEO 2022-12-01 Grant or award · Performance Stock Unit +45,998 45,998 D: show line 3 in the form
Loading xslF345X03/form4.xml…